Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals

被引:25
|
作者
Shafer, RW [1 ]
Warford, A [1 ]
Winters, MA [1 ]
Gonzales, MJ [1 ]
机构
[1] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
关键词
HIV-1; protease; reverse transcriptase;
D O I
10.1016/S0166-0934(00)00144-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The reproducibility of population-based human immunodeficiency virus type 1 (HIV-I) protease and reverse transcriptase (RT) sequencing was assessed using replicate aliquots of cryopreserved plasma samples obtained from seven heavily treated HIV-1-infected individuals. The sequence of each sample replicate was compared with the consensus sequence for that sample and 99.4% of 35128 amino acids were found to be concordant with the sample consensus. Partial discordances were present at 0.5% of positions and complete discordances were present at <0.1% of positions. To assess the reproducibility at detecting mutations (defined here as differences from the subtype B consensus sequence), the proportion of sequences having a mutation when at least two sequences from that sample had the same mutation were examined. There was a median of 13 protease and 18 RT mutations per sample for a total of 3126 mutations; 95% of these mutations were detected. However, sequencing of multiple clones from two samples demonstrated that those mutations present in a minority of clones were often not detected by population-based sequencing. These results suggest that HIV-I protease and RT sequencing of circulating plasma virus is highly reproducible but that the sensitivity at detecting mutations may be low if those mutations are present as minor variants. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 50 条
  • [21] Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-Infected individuals
    Connolly, Nancy C.
    Whiteside, Theresa L.
    Wilson, Cara
    Kondragunta, Venkatswarlu
    Rinaldo, Charles R.
    Riddler, Sharon A.
    CLINICAL AND VACCINE IMMUNOLOGY, 2008, 15 (02) : 284 - 292
  • [22] Metabolic characterization of plasma samples in HIV-1-infected individuals
    Zhang, Ting
    Sun, Jianping
    Du, Haiwei
    Su, Haoxiang
    Zhang, Yonghong
    Jin, Qi
    FUTURE MICROBIOLOGY, 2018, 13 (09) : 985 - 996
  • [23] Pharmacokinetics of [14C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults:: a mass balance study
    McDowell, JA
    Chittick, GE
    Ravitch, JR
    Polk, RE
    Kerkering, TM
    Stein, DS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) : 2855 - 2861
  • [24] Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-Infected women
    Cunningham, CK
    Wara, DW
    Kang, MH
    Fenton, T
    Hawkins, E
    McNamara, J
    Mofenson, L
    Duliege, AM
    Francis, D
    McFarland, EJ
    Borkowsky, W
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) : 801 - 807
  • [25] RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TO NONNUCLEOSIDE HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS
    DECLERCQ, E
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1994, 10 (04): : 145 - 158
  • [26] Analysis of human immunodeficiency virus type 1 (HIV-1) variants and levels of infection in dendritic and T cells from symptomatic HIV-1-infected patients
    Patterson, S
    English, NR
    Longhurst, H
    Balfe, P
    Helbert, M
    Pinching, AJ
    Knight, SC
    JOURNAL OF GENERAL VIROLOGY, 1998, 79 : 247 - 257
  • [27] In vitro inhibition of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase by gold(III) porphyrins
    Sun, RWY
    Yu, WY
    Sun, HZ
    Che, CM
    CHEMBIOCHEM, 2004, 5 (09) : 1293 - 1298
  • [28] Lymphocyte mitochondrial biomarkers in asymptomatic HIV-1-infected individuals treated with nucleoside reverse transcriptase inhibitors
    Henry, K
    Erice, A
    Balfour, HH
    Schmeling, M
    Berthiaume, J
    Wallace, K
    AIDS, 2002, 16 (18) : 2485 - 2487
  • [29] Human Immunodeficiency Virus type 1 in seronegative infants born to HIV-1-infected mothers
    Vázquez Pérez JA
    Basualdo Sigales MC
    Reyes-Terán G
    Gudiño Rosales JC
    Soler Claudín C
    Virology Journal, 3
  • [30] Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro
    Kotler, M
    Simm, M
    Zhao, YS
    Sova, P
    Chao, W
    Ohnona, SF
    Roller, R
    Krachmarov, C
    Potash, MJ
    Volsky, DJ
    JOURNAL OF VIROLOGY, 1997, 71 (08) : 5774 - 5781